University of Washington (UW) School of Dentistry researchers will conduct a first-of-its-kind trial to determine whether an antiaging drug can change immune responses in older adults

Cannabidiol (CBD), the nonpsychoactive compound in cannabis, may inhibit the growth of the periodontitis pathogen Porphyromonas gingivalis (P. gingivalis). The new research will be presented

Gargling with mouthwash may hold significant promise in mitigating the incidence of periodontitis, as well as managing type 2 diabetes mellitus (T2DM), according to a

Drugs commonly prescribed to lower cholesterol may combat the inflammatory response linked to gum disease by altering the conduct of immune cells, known as macrophages,

Getting too few hours of sleep nightly may be associated with a significantly greater risk of developing periodontitis, according to a review recently published in

An artificial intelligence (AI)-powered toothbrush can improve oral hygiene levels and duration, particularly benefiting patients with periodontitis. This research was published in the Journal of

Older adults and men may experience worse outcomes after nonsurgical periodontal treatment (NSPT), suggesting the need for tailored treatment approaches for these patients. This analysis

Alone and together, lifestyle factors like smoking, excessive drinking, and depression may significantly affect the risk of developing periodontitis, according to a study published on

A mouthwash containing matcha, a finely ground powder of green tea, may inhibit the growth of one of the main bacteria involved in periodontitis, indicating

Though largely preventable, periodontal disease poses significant economic and societal burdens, emphasizing a need for policy interventions, according to a review article recently published in

Genetics may be a key player in the development of type 2 diabetes (T2D) related to periodontitis, highlighting potential targets for new treatments, reports research

A drug commonly used to prevent organ transplant rejection, rapamycin, may also treat inflammatory bone loss diseases associated with clonal hematopoiesis of indeterminate potential (CHIP),